Style | Citing Format |
---|---|
MLA | Naziri A, et al.. "Anti-Malarial Activity of Nano Tannic Acid Mgo Extract Alone and Combined With Chloroquine Against Plasmodium Berghei." Journal of Arthropod-Borne Diseases, vol. 18, no. 3, 2025, pp. 264-275. |
APA | Naziri A, Motevalihaghi A, Nateghpour M, Shabani M, Dehdast SA, Rahimiforoushani A, Khezri A, Farzaneh Z (2025). Anti-Malarial Activity of Nano Tannic Acid Mgo Extract Alone and Combined With Chloroquine Against Plasmodium Berghei. Journal of Arthropod-Borne Diseases, 18(3), 264-275. |
Chicago | Naziri A, Motevalihaghi A, Nateghpour M, Shabani M, Dehdast SA, Rahimiforoushani A, Khezri A, Farzaneh Z. "Anti-Malarial Activity of Nano Tannic Acid Mgo Extract Alone and Combined With Chloroquine Against Plasmodium Berghei." Journal of Arthropod-Borne Diseases 18, no. 3 (2025): 264-275. |
Harvard | Naziri A et al. (2025) 'Anti-Malarial Activity of Nano Tannic Acid Mgo Extract Alone and Combined With Chloroquine Against Plasmodium Berghei', Journal of Arthropod-Borne Diseases, 18(3), pp. 264-275. |
Vancouver | Naziri A, Motevalihaghi A, Nateghpour M, Shabani M, Dehdast SA, Rahimiforoushani A, et al.. Anti-Malarial Activity of Nano Tannic Acid Mgo Extract Alone and Combined With Chloroquine Against Plasmodium Berghei. Journal of Arthropod-Borne Diseases. 2025;18(3):264-275. |
BibTex | @article{ author = {Naziri A and Motevalihaghi A and Nateghpour M and Shabani M and Dehdast SA and Rahimiforoushani A and Khezri A and Farzaneh Z}, title = {Anti-Malarial Activity of Nano Tannic Acid Mgo Extract Alone and Combined With Chloroquine Against Plasmodium Berghei}, journal = {Journal of Arthropod-Borne Diseases}, volume = {18}, number = {3}, pages = {264-275}, year = {2025} } |
RIS | TY - JOUR AU - Naziri A AU - Motevalihaghi A AU - Nateghpour M AU - Shabani M AU - Dehdast SA AU - Rahimiforoushani A AU - Khezri A AU - Farzaneh Z TI - Anti-Malarial Activity of Nano Tannic Acid Mgo Extract Alone and Combined With Chloroquine Against Plasmodium Berghei JO - Journal of Arthropod-Borne Diseases VL - 18 IS - 3 SP - 264 EP - 275 PY - 2025 ER - |